Amazon + One Medical
This week the PharmaTell Team had Eyes On Pharma Tech Outlook …
Home »
Intel
PharmaTell Is In the Top 10!
This week the PharmaTell Team had Eyes On Pharma Tech Outlook …
Pharma CI Europe Conference + US FDA Updates + Clinical Data Readouts
We’ve had a busy couple of weeks with the Pharma CI Europe Conference and month end updates. Take a look at what the PharmaTell Team had Eyes on this week.
ASCO + Good News for PPD Patients
As with most of you I’m sure – this week the PharmaTell Team had Eyes on ASCO + positive data for postpartum depression patients.
Product Approvals, Delays, & Disappointments
The PharmaTell team had Eyes on new products this week – watching Lilly’s Mounjaro approval, UCB’s Bimzelx CRL, and Roche’s SKYSCRAPER-1 data.
Quarterly Results, Biogen, & Conference Planning
The PharmaTell Team has been busy this week curating Quarterly Results Reports & upcoming conference planners + keeping up with Biogen next steps.
AACR Updates & CAR-T Overview
This week the team has been enjoying the Spring Holidays, Reviewing the AACR Highlights, and Learning about CAR-T.
Patient Volumes Recovering + Aduhelm
This week we had Eyes on Patient Volumes – post-COVID recovery + the CMS Final say on Aduhelm Coverage.
PharmaTell Studio Upgrades
This week we want to share the latest upgrades to PharmaTell Studio. As always we are innovating to help you keep your eyes on you & your competition.
FDA Approvals, Transcripts, & Conferences
This week the team has been looking at congress planners, transcripts, and the US FDA.